{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T01:17:47Z","timestamp":1791940667779,"version":"4.3.4"},"reference-count":76,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,7]],"date-time":"2023-10-07T00:00:00Z","timestamp":1696636800000},"content-version":"vor","delay-in-days":371,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01HL126724"],"award-info":[{"award-number":["R01HL126724"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01HL144552"],"award-info":[{"award-number":["R01HL144552"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01HL157975\u201001A1"],"award-info":[{"award-number":["R01HL157975\u201001A1"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005881","name":"Hemostasis and Thrombosis Research Society","doi-asserted-by":"publisher","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/100005881","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1111\/jth.15822","type":"journal-article","created":{"date-parts":[[2022,7,17]],"date-time":"2022-07-17T14:14:11Z","timestamp":1658067251000},"page":"2197-2203","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["ADAMTS13 conformations and mechanism of inhibition in immune thrombotic thrombocytopenic purpura"],"prefix":"10.1016","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9594-1852","authenticated-orcid":false,"given":"Konstantine","family":"Halkidis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1680-5295","authenticated-orcid":false,"given":"X. Long","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/jth.15822_bb0010","doi-asserted-by":"crossref","first-page":"41059","DOI":"10.1074\/jbc.C100515200","article-title":"Structure of von Willebrand factor\u2010cleaving protease (ADAMTS13), a metalloprotease involved in thrombotic thrombocytopenic purpura","volume":"276","author":"Zheng","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1111\/jth.15822_bb0015","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/00062752-200209000-00001","article-title":"ADAMTS13 and TTP","volume":"9","author":"Zheng","year":"2002","journal-title":"Curr Opin Hematol"},{"key":"10.1111\/jth.15822_bb0020","doi-asserted-by":"crossref","first-page":"857","DOI":"10.3949\/ccjm.68.10.857","article-title":"Thrombotic thrombocytopenic purpura\u2010hemolytic uremic syndrome: diagnosis and treatment","volume":"68","author":"George","year":"2001","journal-title":"Cleve Clin J Med"},{"key":"10.1111\/jth.15822_bb0025","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1023\/A:1011921122595","article-title":"Thrombotic thrombocytopenic purpura (TTP) and hemolytic uremic syndrome (HUS): the new thinking","volume":"11","author":"Liu","year":"2001","journal-title":"J Thromb Thrombolysis"},{"key":"10.1111\/jth.15822_bb0030","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1046\/j.1525-1438.2002.00080.x","article-title":"Thrombotic thrombocytopenic purpura and hemolytic uremic syndrome: will recent insight into pathogenesis translate into better treatment?","volume":"42","author":"Kelton","year":"2002","journal-title":"Transfusion"},{"key":"10.1111\/jth.15822_bb0035","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1055\/s-2005-925468","article-title":"Pathogenesis of thrombotic thrombocytopenic purpura: ADAMTS13 deficiency and beyond","volume":"31","author":"Lian","year":"2005","journal-title":"Semin Thromb Hemost"},{"issue":"Suppl 1","key":"10.1111\/jth.15822_bb0040","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1080\/10245330512331389890","article-title":"The role of ADAMTS13 in the new pathogenesis of TTP","volume":"10","author":"Peyvandi","year":"2005","journal-title":"Hematology"},{"key":"10.1111\/jth.15822_bb0045","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJM199108083250604","article-title":"Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Canadian Apheresis Study Group","volume":"325","author":"Rock","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1111\/jth.15822_bb0050","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0002-9343(99)00286-7","article-title":"Improved survival with plasma exchange in patients with thrombotic thrombocytopenic purpura\u2010hemolytic uremic syndrome","volume":"107","author":"Lara","year":"1999","journal-title":"Am J Med"},{"key":"10.1111\/jth.15822_bb0055","doi-asserted-by":"crossref","first-page":"4043","DOI":"10.1182\/blood-2003-11-4035","article-title":"Effect of plasma exchange on plasma ADAMTS13 metalloprotease activity, inhibitor level, and clinical outcome in patients with idiopathic and nonidiopathic thrombotic thrombocytopenic purpura","volume":"103","author":"Zheng","year":"2004","journal-title":"Blood"},{"key":"10.1111\/jth.15822_bb0060","first-page":"307","article-title":"A clinical research project to study plasma exchange and plasma infusion in treatment of thrombotic thrombocytopenic purpura (TTP)","volume":"106","author":"Rock","year":"1982","journal-title":"Prog Clin Biol Res"},{"key":"10.1111\/jth.15822_bb0065","first-page":"125","article-title":"A study of plasma exchange in TTP. The Canadian Apheresis Study Group","volume":"337","author":"Rock","year":"1990","journal-title":"Prog Clin Biol Res"},{"issue":"Suppl 1","key":"10.1111\/jth.15822_bb0070","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1423-0410.2002.tb05288.x","article-title":"Plasma exchange in the management of thrombotic thrombocytopenic purpura","volume":"83","author":"Rock","year":"2002","journal-title":"Vox Sang"},{"key":"10.1111\/jth.15822_bb0075","doi-asserted-by":"crossref","first-page":"105","DOI":"10.7326\/0003-4819-138-2-200301210-00011","article-title":"Remission of chronic thrombotic thrombocytopenic purpura after treatment with cyclophosphamide and rituximab","volume":"138","author":"Zheng","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.1111\/jth.15822_bb0080","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/j.1399-0012.2005.00334.x","article-title":"Anti\u2010CD20 monoclonal antibody (Rituximab) for life\u2010threatening hemolytic\u2010uremic syndrome","volume":"19","author":"Yassa","year":"2005","journal-title":"Clin Transplant"},{"key":"10.1111\/jth.15822_bb0085","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1097\/01.moh.0000170534.33517.99","article-title":"Immunotherapy for thrombotic thrombocytopenic purpura","volume":"12","author":"Cataland","year":"2005","journal-title":"Curr Opin Hematol"},{"key":"10.1111\/jth.15822_bb0090","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1182\/blood-2018-04-840090","article-title":"Preemptive rituximab prevents long\u2010term relapses in immune\u2010mediated thrombotic thrombocytopenic purpura","volume":"132","author":"Jestin","year":"2018","journal-title":"Blood"},{"key":"10.1111\/jth.15822_bb0095","doi-asserted-by":"crossref","DOI":"10.1177\/1076029618825309","article-title":"Comparison of the long\u2010term remission of rituximab and conventional treatment for acquired thrombotic thrombocytopenic purpura: a systematic review and meta\u2010analysis","volume":"25","author":"Owattanapanich","year":"2019","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1111\/jth.15822_bb0100","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/nrneph.2016.47","article-title":"Thrombotic microangiopathy: caplacizumab accelerates resolution of acute acquired TTP","volume":"12","author":"Lammle","year":"2016","journal-title":"Nat Rev Nephrol"},{"key":"10.1111\/jth.15822_bb0105","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1111\/jth.13716","article-title":"Caplacizumab reduces the frequency of major thromboembolic events, exacerbations and death in patients with acquired thrombotic thrombocytopenic purpura","volume":"15","author":"Peyvandi","year":"2017","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.15822_bb0110","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/rth2.12160","article-title":"Thrombotic thrombocytopenic purpura: toward targeted therapy and precision medicine","volume":"3","author":"Coppo","year":"2019","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1111\/jth.15822_bb0115","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/tme.12615","article-title":"Caplacizumab treatment for acquired thrombotic thrombocytopenic purpura (HERCULES trial)","volume":"29","author":"Estcourt","year":"2019","journal-title":"Transfus Med"},{"key":"10.1111\/jth.15822_bb0120","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1111\/bjh.16977","article-title":"Caplacizumab treatment for acquired refractory thrombotic thrombocytopenic purpura","volume":"191","author":"Khan","year":"2020","journal-title":"Br J Haematol"},{"key":"10.1111\/jth.15822_bb0125","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1182\/bloodadvances.2019001375","article-title":"Antibodies that conformationally activate ADAMTS13 allosterically enhance metalloprotease domain function","volume":"4","author":"Schelpe","year":"2020","journal-title":"Blood Adv"},{"key":"10.1111\/jth.15822_bb0130","first-page":"353","article-title":"Open ADAMTS13, induced by antibodies, is a biomarker for subclinical immune\u2010mediated thrombotic thrombocytopenic purpura","volume":"136","author":"Roose","year":"2020","journal-title":"Blood"},{"key":"10.1111\/jth.15822_bb0135","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.3324\/haematol.2019.226068","article-title":"Modifying ADAMTS13 to modulate binding of pathogenic autoantibodies of patients with acquired thrombotic thrombocytopenic purpura","volume":"105","author":"Graca","year":"2020","journal-title":"Haematologica"},{"key":"10.1111\/jth.15822_bb0140","doi-asserted-by":"crossref","first-page":"3781","DOI":"10.1038\/s41467-019-11474-5","article-title":"Hrombotic thrombocytopenic purpura\u2010hemolytic uremic syndrome: diagnosis and treatment","volume":"10","author":"Petri","year":"2019","journal-title":"Nat Commun"},{"key":"10.1111\/jth.15822_bb0145","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1182\/blood-2018-11-886309","article-title":"Exploring the \"minimal\" structure of a functional ADAMTS13 by mutagenesis and small\u2010angle X\u2010ray scattering","volume":"133","author":"Zhu","year":"2019","journal-title":"Blood"},{"key":"10.1111\/jth.15822_bb0150","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1182\/blood-2018-11-886275","article-title":"Phylogenetic and functional analysis of ADAMTS13 identifies highly conserved domains essential for allosteric regulation","volume":"133","author":"Muia","year":"2019","journal-title":"Blood"},{"key":"10.1111\/jth.15822_bb0155","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1111\/jth.15332","article-title":"A human monoclonal antibody against the distal carboxyl terminus of ADAMTS\u201013 modulates its susceptibility to an inhibitor in thrombotic thrombocytopenic purpura","volume":"19","author":"Halkidis","year":"2021","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.15822_bb0160","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1111\/jth.13149","article-title":"Linker regions and flexibility around the metalloprotease domain account for conformational activation of ADAMTS\u201013","volume":"13","author":"Deforche","year":"2015","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.15822_bb0165","doi-asserted-by":"crossref","first-page":"18584","DOI":"10.1073\/pnas.1413282112","article-title":"Allosteric activation of ADAMTS13 by von Willebrand factor","volume":"111","author":"Muia","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/jth.15822_bb0170","doi-asserted-by":"crossref","first-page":"9620","DOI":"10.1073\/pnas.1512561112","article-title":"High\u2010resolution epitope mapping by HX MS reveals the pathogenic mechanism and a possible therapy for autoimmune TTP syndrome","volume":"112","author":"Casina","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/jth.15822_bb0175","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1111\/jth.13445","article-title":"Conformational quiescence of ADAMTS13 prevents proteolytic promiscuity","volume":"14","author":"South","year":"2016","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.15822_bb0180","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1182\/blood-2013-11-538173","article-title":"Control of VWF A2 domain stability and ADAMTS13 access to the scissile bond of full\u2010length VWF","volume":"123","author":"Lynch","year":"2014","journal-title":"Blood"},{"key":"10.1111\/jth.15822_bb0185","doi-asserted-by":"crossref","first-page":"18578","DOI":"10.1073\/pnas.1411979112","article-title":"Conformational activation of ADAMTS13","volume":"111","author":"South","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1111\/jth.15822_bb0190","doi-asserted-by":"crossref","first-page":"3064","DOI":"10.1182\/blood-2009-12-258780","article-title":"The ADAMTS13 metalloprotease domain: roles of subsites in enzyme activity and specificity","volume":"116","author":"de Groot","year":"2010","journal-title":"Blood"},{"key":"10.1111\/jth.15822_bb0195","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/35097008","article-title":"Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura","volume":"413","author":"Levy","year":"2001","journal-title":"Nature"},{"key":"10.1111\/jth.15822_bb0200","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1182\/blood.V98.6.1654","article-title":"Partial amino acid sequence of purified von Willebrand factor\u2010cleaving protease","volume":"98","author":"Gerritsen","year":"2001","journal-title":"Blood"},{"key":"10.1111\/jth.15822_bb0205","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1182\/blood.V98.6.1662","article-title":"Purification of human von Willebrand factor\u2010cleaving protease and its identification as a new member of the metalloproteinase family","volume":"98","author":"Fujikawa","year":"2001","journal-title":"Blood"},{"key":"10.1111\/jth.15822_bb0210","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1093\/oxfordjournals.jbchem.a003009","article-title":"A novel human metalloprotease synthesized in the liver and secreted into the blood: possibly, the von Willebrand factor\u2010cleaving protease?","volume":"130","author":"Soejima","year":"2001","journal-title":"J Biochem"},{"issue":"Suppl 1","key":"10.1111\/jth.15822_bb0215","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/jth.12221","article-title":"Structure\u2010function and regulation of ADAMTS\u201013 protease","volume":"11","author":"Zheng","year":"2013","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.15822_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmb.2021.166954","article-title":"An integrative structural biology analysis of von Willebrand factor binding and processing by ADAMTS\u201013 in solution","volume":"433","author":"Del Amo\u2010Maestro","year":"2021","journal-title":"J Mol Biol"},{"key":"10.1111\/jth.15822_bb0225","doi-asserted-by":"crossref","first-page":"19274","DOI":"10.1073\/pnas.0909755106","article-title":"Crystal structures of the noncatalytic domains of ADAMTS13 reveal multiple discontinuous exosites for von Willebrand factor","volume":"106","author":"Akiyama","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/jth.15822_bb0230","doi-asserted-by":"crossref","first-page":"29428","DOI":"10.1074\/jbc.M505513200","article-title":"The proximal carboxyl\u2010terminal domains of ADAMTS13 determine substrate specificity and are all required for cleavage of von Willebrand factor","volume":"280","author":"Ai","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1111\/jth.15822_bb0235","doi-asserted-by":"crossref","first-page":"30136","DOI":"10.1074\/jbc.M305331200","article-title":"Cleavage of von Willebrand factor requires the spacer domain of the metalloprotease ADAMTS13","volume":"278","author":"Zheng","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1111\/jth.15822_bb0240","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1161\/ATVBAHA.111.229609","article-title":"Essential domains of a disintegrin and metalloprotease with thrombospondin type 1 repeats\u201013 metalloprotease required for modulation of arterial thrombosis","volume":"31","author":"Xiao","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"3825\u20139","key":"10.1111\/jth.15822_bb0245","first-page":"S1","article-title":"AAV\u2010mediated expression of an ADAMTS13 variant prevents shigatoxin\u2010induced thrombotic thrombocytopenic purpura","volume":"121","author":"Jin","year":"2013","journal-title":"Blood"},{"key":"10.1111\/jth.15822_bb0250","doi-asserted-by":"crossref","first-page":"5760","DOI":"10.1074\/jbc.M117.776732","article-title":"A model for the conformational activation of the structurally quiescent metalloprotease ADAMTS13 by von Willebrand factor","volume":"292","author":"South","year":"2017","journal-title":"J Biol Chem"},{"key":"10.1111\/jth.15822_bb0255","doi-asserted-by":"crossref","first-page":"eabg4403","DOI":"10.1126\/sciadv.abg4403","article-title":"Crystal structure of ADAMTS13 CUB domains reveals their role in global latency","volume":"7","author":"Kim","year":"2021","journal-title":"Sci Adv"},{"key":"10.1111\/jth.15822_bb0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmgm.2021.108029","article-title":"Characterization of the interactions of ADAMTS13 CUB1 domain to WT\u2010 and GOF\u2010Spacer domain by molecular dynamics simulation","volume":"109","author":"Yang","year":"2021","journal-title":"J Mol Graph Model"},{"key":"10.1111\/jth.15822_bb0265","doi-asserted-by":"crossref","first-page":"3836","DOI":"10.1182\/blood-2011-12-399501","article-title":"Gain\u2010of\u2010function ADAMTS13 variants that are resistant to autoantibodies against ADAMTS13 in patients with acquired thrombotic thrombocytopenic purpura","volume":"119","author":"Jian","year":"2012","journal-title":"Blood"},{"key":"10.1111\/jth.15822_bb0270","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1111\/jth.14602","article-title":"Identification of cysteine thiol\u2010based linkages in ADAMTS13 in support of a non\u2010proteolytic regulation of von Willebrand factor","volume":"17","author":"Rottensteiner","year":"2019","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.15822_bb0275","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1097\/MOH.0000000000000602","article-title":"Insights into ADAMTS13 structure: impact on thrombotic thrombocytopenic purpura diagnosis and management","volume":"27","author":"Roose","year":"2020","journal-title":"Curr Opin Hematol"},{"key":"10.1111\/jth.15822_bb0280","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1111\/jth.15170","article-title":"Immunogenic hotspots in the spacer domain of ADAMTS13 in immune\u2010mediated thrombotic thrombocytopenic purpura","volume":"19","author":"Velasquez Pereira","year":"2021","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.15822_bb0285","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1111\/trf.13584","article-title":"ADAMTS13 autoantibodies cloned from patients with acquired thrombotic thrombocytopenic purpura: 1. Structural and functional characterization in vitro","volume":"56","author":"Ostertag","year":"2016","journal-title":"Transfusion"},{"key":"10.1111\/jth.15822_bb0290","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/j.ebiom.2015.06.007","article-title":"Pathogenicity of anti\u2010ADAMTS13 autoantibodies in acquired thrombotic thrombocytopenic purpura","volume":"2","author":"Thomas","year":"2015","journal-title":"EBioMedicine"},{"key":"10.1111\/jth.15822_bb0295","doi-asserted-by":"crossref","first-page":"e79","DOI":"10.1016\/j.thromres.2012.06.006","article-title":"Identification of epitopes on ADAMTS13 recognized by a panel of monoclonal antibodies with functional or non\u2010functional effects on catalytic activity","volume":"130","author":"Igari","year":"2012","journal-title":"Thromb Res"},{"key":"10.1111\/jth.15822_bb0300","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1182\/asheducation.V2012.1.610.3798654","article-title":"Role of ADAMTS13 in the pathogenesis, diagnosis, and treatment of thrombotic thrombocytopenic purpura","volume":"2012","author":"Kremer Hovinga","year":"2012","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"10.1111\/jth.15822_bb0305","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.3324\/haematol.2010.036327","article-title":"Residues Arg568 and Phe592 contribute to an antigenic surface for anti\u2010ADAMTS13 antibodies in the spacer domain","volume":"96","author":"Pos","year":"2011","journal-title":"Haematologica"},{"key":"10.1111\/jth.15822_bb0310","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.thromres.2011.03.010","article-title":"Epitope analysis of autoantibodies to ADAMTS13 in patients with acquired thrombotic thrombocytopenic purpura","volume":"128","author":"Yamaguchi","year":"2011","journal-title":"Thromb Res"},{"key":"10.1111\/jth.15822_bb0315","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.3324\/haematol.2009.019299","article-title":"Multiple domains of ADAMTS13 are targeted by autoantibodies against ADAMTS13 in patients with acquired idiopathic thrombotic thrombocytopenic purpura","volume":"95","author":"Zheng","year":"2010","journal-title":"Haematologica"},{"key":"10.1111\/jth.15822_bb0320","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1160\/TH04-05-0301","article-title":"The spacer domain of ADAMTS13 contains a major binding site for antibodies in patients with thrombotic thrombocytopenic purpura","volume":"93","author":"Luken","year":"2005","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.15822_bb0325","doi-asserted-by":"crossref","first-page":"4514","DOI":"10.1182\/blood-2003-12-4165","article-title":"Epitope mapping of ADAMTS13 autoantibodies in acquired thrombotic thrombocytopenic purpura","volume":"103","author":"Klaus","year":"2004","journal-title":"Blood"},{"key":"10.1111\/jth.15822_bb0330","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1111\/trf.13583","article-title":"ADAMTS13 autoantibodies cloned from patients with acquired thrombotic thrombocytopenic purpura: 2. Pathogenicity in an animal model","volume":"56","author":"Ostertag","year":"2016","journal-title":"Transfusion"},{"key":"10.1111\/jth.15822_bb0335","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/jth.13922","article-title":"An open conformation of ADAMTS\u201013 is a hallmark of acute acquired thrombotic thrombocytopenic purpura","volume":"16","author":"Roose","year":"2018","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.15822_bb0340","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0160388","article-title":"Generation of anti\u2010Murine ADAMTS13 antibodies and their application in a mouse model for acquired thrombotic thrombocytopenic purpura","volume":"11","author":"Deforche","year":"2016","journal-title":"PLoS One"},{"key":"10.1111\/jth.15822_bb0345","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1365-2141.2005.05420.x","article-title":"FRETS\u2010VWF73, a first fluorogenic substrate for ADAMTS13 assay","volume":"129","author":"Kokame","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1111\/jth.15822_bb0350","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1529\/biophysj.108.131532","article-title":"Mechanistic studies on ADAMTS13 catalysis","volume":"95","author":"Di Stasio","year":"2008","journal-title":"Biophys J"},{"key":"10.1111\/jth.15822_bb0355","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1055\/s-0038-1669459","article-title":"Anti\u2010ADAMTS13 autoantibodies against cryptic epitopes in immune\u2010mediated thrombotic thrombocytopenic purpura","volume":"118","author":"Roose","year":"2018","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.15822_bb0360","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1182\/blood-2009-07-235101","article-title":"Amino acid residues Arg(659), Arg(660), and Tyr(661) in the spacer domain of ADAMTS13 are critical for cleavage of von Willebrand factor","volume":"115","author":"Jin","year":"2010","journal-title":"Blood"},{"key":"10.1111\/jth.15822_bb0365","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1074\/jbc.M508316200","article-title":"ADAMTS13 substrate recognition of von Willebrand factor A2 domain","volume":"281","author":"Zanardelli","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1111\/jth.15822_bb0370","doi-asserted-by":"crossref","first-page":"6511","DOI":"10.1021\/bi9619177","article-title":"Can a two\u2010state MWC allosteric model explain hemoglobin kinetics?","volume":"36","author":"Henry","year":"1997","journal-title":"Biochemistry"},{"key":"10.1111\/jth.15822_bb0375","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0301-4622(98)00202-6","article-title":"Hemoglobin\u2010oxygen\u2010carbon monoxide equilibria with the MWC model","volume":"75","author":"Senozan","year":"1998","journal-title":"Biophys Chem"},{"key":"10.1111\/jth.15822_bb0380","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1016\/j.bpj.2021.04.024","article-title":"MWC allosteric model explains unusual hemoglobin\u2010oxygen binding curves from sickle cell drug binding","volume":"120","author":"Henry","year":"2021","journal-title":"Biophys J"},{"key":"10.1111\/jth.15822_bb0385","doi-asserted-by":"crossref","first-page":"16209","DOI":"10.1021\/jp106968p","article-title":"Specificity of non\u2010Michaelis\u2010Menten enzymes: necessary information for analyzing metabolic pathways","volume":"114","author":"Cornish\u2010Bowden","year":"2010","journal-title":"J Phys Chem B"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jth.15822","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/jth.15822","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622190550?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622190550?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jth.15822","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T03:36:20Z","timestamp":1761536180000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783622190550"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":76,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["S1538783622190550"],"URL":"https:\/\/doi.org\/10.1111\/jth.15822","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ADAMTS13 conformations and mechanism of inhibition in immune thrombotic thrombocytopenic purpura","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/jth.15822","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2022 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}